TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI (Q2031397): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 06:54, 2 November 2020
Project Q2031397 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI |
Project Q2031397 in Italy |
Statements
84,000.0 Euro
0 references
168,000.0 Euro
0 references
50.0 percent
0 references
22 July 2016
0 references
30 April 2019
0 references
UFF_EFATTURAPA
0 references
45°40'37.52"N, 13°45'12.31"E
0 references
IL PROGETTO PREVEDE LO STUDIO IN VITRO SU CULTURE PRIMARIE E LINEE CELLULARI DELLA TOSSICITÃ DEI SISTEMI DI DRUG DELIVERY SVILUPPATI DA NEALYS (B1) E L'EFFICACIA DEL TARGETTING SELETTIVO. SUCCESSIVAMENTE I SISTEMI SELEZIONATI E CARICATI CON FARMACI ANTITUMORALI SARANNO TESTATI IN VITRO SU LINEE CELLULARI DI CARCINOMA OVARICO. INOLTRE, A PARTIRE DA BIOPSIE DI TUMORE OVARICO DI PAZIENTE SARANNO ALLESTITE COLTURE ORGANOTIPICHE ED ESPERIMENTI DI XENOGRAFT IN MODELLI ANIMALI PER VALIDARE LE MOLECOL (Italian)
0 references
THE PROJECT PROVIDES FOR AN IN VITRO STUDY ON PRIMARY CULTURES AND CELL LINES OF THE DRUG DELIVERY SYSTEMS DEVELOPED BY NEALYS (B1) AND THE EFFECTIVENESS OF THE SELECTIVE TARGETING SYSTEM. SUBSEQUENTLY, SYSTEMS SELECTED AND UPLOADED WITH CANCER DRUGS WILL BE TESTED IN VITRO ON OVARIAN CANCER LINES. IN ADDITION, FROM BIOPSIES OF OVARIAN CANCER, ORGANIOTIPITA CULTURES AND EXPERIMENTS OF XENMOGRAPHY WILL BE ESTABLISHED IN ANIMALS MODELS FOR THE VALIDATION OF MOLCOL. (English)
0 references
Identifiers
C92F17000310007
0 references